文章
醫療新知 > 丹麥人工卵巢新科技 可望協助癌癒婦女懷孕  / Artificial ovaries could help young cancer patients preserve their fertility, and this is a game-changer

丹麥人工卵巢新科技 可望協助癌癒婦女懷孕  / Artificial ovaries could help young cancer patients preserve their fertility, and this is a game-changer

05-07-2018

丹麥人工卵巢新科技 可望協助癌癒婦女懷孕 

(法新社資料圖片)

 

丹麥科學加宣布研發人工卵巢新技術,將來可望有助曾接受化療、放射治療等婦女重拾生育能力。

現有醫學技術主要有兩種方法,助有婦女保留生育能力。第一種是選擇冷藏卵子,待治癒癌症後,再用人工授孕方法生育。另一方法是移除和冷藏部分卵巢組織,治病後再植回病人體內。不過,由於原有卵巢組織可能殘留癌細胞,因此第二種方法風險較高亦較少用。

哥本哈根國家醫院(Rigshospitalet)生殖生物學實驗室博士後研究員波爾什(Susanne Pors)及其他專家研究人工卵巢技術。研究人員先抽取女病人自身或由別人捐贈的卵巢組織,再用化學方法清除當中所有細胞,以杜絕癌細胞殘留風險,只餘下蛋白質和膠原蛋白組成的「去細胞支架」(decellularized scaffold),亦即人工卵巢。

專家再把預先冷藏的病人卵泡(follicle)「種回」人工卵巢。由於卵泡在人類胚胎時期已形成,亦有保護膜保護,因此可確保癌細胞不能入侵。專家以老鼠體內所做試驗顯示,人工卵巢能夠支持卵泡生長。

研究結果周一(2日)在西班牙巴塞隆拿舉行的歐洲生殖醫學會年度會議上發表,專家強調這種技術尚需驗證。

(美國有線新聞網絡/英國廣播公司)

***********************************************************************************************************************************

Artificial ovaries could help young cancer patients preserve their fertility, and this is a game-changer

 

While many people are familiar with women freezing their eggs to extend or preserve their reproductive abilities, a new fertility method could soon offer a new option. CNN reports that Danish researchers have created an artificial ovary that may preserve fertility for young cancer patients. Ovaries produce eggs, and some cancer treatments damage the ovaries, which can lead to infertility. So these artificial ovaries could possibly help women treat their cancer without having the additional concern of losing the ability to have biological children.

The American Cancer Society notes that both chemotherapy and radiation therapies can damage the ovaries. Currently, women have the options of freezing eggs, embryos, or pieces of their ovaries, or undergoing infertility treatment after cancer as a way to conceive. But a team at the Laboratory of Reproductive Biology at the University Hospital of Copenhagen Rigshospitalet have created yet another option.

The researchers believed that they could bioengineer a “scaffold” of ovarian tissue that contains no cancer. Then, early-stage follicles could grow naturally into fully functional ovarian follicles on this scaffold. In the female body, ovarian follicles each contain one egg that matures during the menstrual cycle. The scientists were able to make the follicles grow on the scaffold, which could allow a woman with damaged ovaries to have children.

 

“This is the first time that isolated human follicles have survived in a decellularized human scaffold,” the authors of the study noted.

 

An artificial ovary may soon be possible, according to researchers who have engineered an ovarian “scaffold” on which early-stage cells can develop into functional follicles https://cnn.it/2MES1oQ

 

One of the authors, Dr. Susanne Pors, explained to CNN in an email how the artificial ovary would work in the real world. “The artificial ovary will consist of a scaffold (originating from the woman’s own tissue or from donated tissue) combined with her own follicles,” Pors wrote. “It is newly constructed, but biological.”

According to USA Today, the researchers presented their findings at the European Society of Human Reproduction and Embryology annual meeting on July 2nd. “We have now done the first important steps towards constructing a cancer-free ovary,” Pors said. “We have many more studies to do, but this is a proof-of-concept showing that human eggs can survive on a newly constructed scaffold.”

There is still much work to be done before these artificial ovaries can be used. And both USA Today and CNN noted that other scientists not involved in the study have expressed their uncertainty about whether or not these experimental ovaries will be successful. But if they are, the artificial ovaries could help extend the fertility of young female cancer patients who don’t want to give up the hope of having biological children.

 

 

疑難排解

會員註冊


或許你會想看
港大醫學院中醫藥學院舉辦第13屆龐鼎元國際中醫藥研討會 匯聚本地海外專家推動中醫藥與中西醫結合
港大醫學院中醫藥學院舉辦第13屆龐鼎元國際中醫藥研討會 匯聚本地海外專家推動中醫藥與中西醫結合 香港大學李嘉誠 […]
中大研發經動脈碘栓塞化療無水新藥物配方治療肝細胞癌 無惡化存活期顯著延長一倍
中大研發經動脈碘栓塞化療無水新藥物配方治療肝細胞癌 無惡化存活期顯著延長一倍 肝癌位列本港第三大癌症殺手,亦是 […]
「2026 保誠健康論壇:優化患者醫療體驗」 薈聚醫療界領袖 共同支援香港及大灣區患者
「2026 保誠健康論壇:優化患者醫療體驗」 薈聚醫療界領袖 共同支援香港及大灣區患者   保誠保險 […]
【活動花絮】推動中西醫結合治療——乳癌研討會 圓滿落幕
由 癌症資訊網慈善基金 主辦的「推動中西醫結合治療 – 乳癌交流研討會」於今日 (2026年3月2 […]
【早期肺癌】術後輔助治療 減低復發風險
早期肺癌是有機會治癒,術後輔助治療減低復發風險 | 劉穎虹醫生 肺癌雖然係香港頭號癌症殺手,但早期肺癌是有機會 […]
【亞洲首研究】5 次質子治療控早期前列腺癌
亞洲首研究:5 次質子治療控早期前列腺癌 養和癌症中心備精準定位技術 引領「大劑量少次數」演進 (2026 年 […]
【活動花絮】肝好有您 | 聽講座・測健康
「肝好有您 | 聽講座・測健康」活動已成功舉辦! 本次活動包含健康講座、乙肝快速檢測及健康街站,吸引了眾多市民 […]
【傳媒報道】晚期大腸癌治療迎來新突破:從精準檢測到免疫治療記者會
【urbanlifehk】大腸癌治療特定晚期患者五年存活率由9% 躍升至70%!專家籲精準檢測配雙免疫治療 勿 […]
最新為亞洲人而設的(Pan-Asian ESMO)胰臟癌臨床指引 提出術後可用口服化療藥物減低復發風險
有「癌中之王」稱號的胰臟癌,不算是常見癌症,卻位列癌症殺手第四位,不但反映了胰臟癌之惡,也體現治療此癌的挑戰性 […]
新型「標靶放射治療」 治療晚期前列腺癌效果理想 有望成為未來前列腺癌治療主流
(2026 年 2 月 10 日) 近年,世界各地也有不少名人、官員被發現患上與前列腺相關疾病,社會大眾亦開始 […]
養和醫療集團及香港理工大學 簽訂培訓合作協議 支援營養治療理學碩士課程 提供實習機會接通教學與臨床
(2026 年 2 月 2 日-香港)養和醫療集團 (養和) 與香港理工大學(理大)簽訂合作協議,為理大在香港 […]
【跨境醫療】「醫健通」新增三間可授權指定境外醫療機構存入放射檢查報告
由一月二十七日起,香港市民可透過「醫健通」流動應用程式的「個人資料夾」功能,授權指定境外醫療機構,為他們上載放 […]